Rosetta Genomics Reports Second Quarter 2010 Financial Results
On a non-GAAP basis, excluding stock-compensation expense, the net loss from continuing operations for the 2010 second quarter was $3.3 million or $0.20 per ordinary share. This compares with a non-GAAP net loss from continuing operations for the 2009 second quarter of $3.5 million or $0.26 per ordinary share.
For the six months ended June 30, 2010 the Company reported revenues from continuing operations of $97,000, compared with revenues from continuing operations of $31,000 in the comparable prior year period. The Company’s net loss from continuing operations in the first half of 2010 was $7.8 million or $0.48 per ordinary share, compared with a net loss from continuing operations of $7.2 million or $0.56 per ordinary share in the same period of 2009.
On a non-GAAP basis, excluding stock-compensation expense, the net loss from continuing operations for the first half of 2010 was $6.7 million or $0.40 per ordinary share. This compares with a non-GAAP net loss from continuing operations for the first half of 2009 of $6.7 million or $0.52 per ordinary share.
Details reconciling non-GAAP amounts with GAAP amounts are provided in the table below.Rosetta Genomics ended the second quarter of 2010 with $7.7 million in cash and cash equivalents, short-term bank deposit and marketable securities, compared with $10.3 million as of December 31, 2009. Conference Call Rosetta Genomics management will host a conference call on Wednesday, September 8, 2010 beginning at 10:00 a.m. Eastern time to discuss second quarter 2010 financial results and recent corporate developments, and answer questions. To access the live conference call, U.S. and Canadian participants may dial (866) 239-5859; international participants may dial (702) 495-1913. The access code for the call is 89504316. To access the audio replay, beginning two hours after the event U.S. and Canadian participants may dial (800) 642-1687; international participants may dial (706) 645-9291. The access code for the replay is 89504316. The replay will be available through 12 midnight Eastern time on September 10, 2010.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV